Larimar Therapeutics Reports Lower-than-Expected GAAP Earnings Per Share
Thursday, 14 March 2024, 21:09
Larimar Therapeutics GAAP EPS Report
The latest report from Larimar Therapeutics revealed a GAAP EPS of -$0.30, failing to meet the projected earnings by $0.06.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.